{"id":10721,"date":"2020-01-01T11:45:25","date_gmt":"2020-01-01T06:15:25","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=10721"},"modified":"2026-07-30T21:38:43","modified_gmt":"2026-07-30T16:08:43","slug":"a-pizza-hut-prescription-for-gene-therapy-companies","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/","title":{"rendered":"A Pizza Hut Prescription for Gene Therapy Companies"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-1024x683.webp\" alt=\"Gene Therapy market ready to take-off \" class=\"wp-image-16201\" style=\"object-fit:contain;width:800px;height:536px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-1024x683.webp 1024w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-300x200.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-768x512.webp 768w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-1536x1024.webp 1536w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_Pizza_Prescription_Gene_Therapy_Market-2048x1366.webp 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">As we enter 2020, one drug class that is set to take-off is <em>gene therapy<\/em>. With three approvals (<a href=\"https:\/\/www.novartis.com\/news\/media-releases\/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma\">Zolgensma<\/a>\u00ae (US), <a href=\"http:\/\/investor.bluebirdbio.com\/news-releases\/news-release-details\/bluebird-bio-announces-eu-conditional-marketing-authorization\">Zynteglo<\/a>\u2122 (Europe) and Beperminogene Perplasmid (Japan), 2019 was a break out year for gene therapy developers. The <a href=\"https:\/\/www.rootsanalysis.com\/blog\/2019\/10\/15\/10320\/\">$16 billion-plus investment <\/a>by various investors finally seems to be paying off as we enter 2020 with a gene therapy pipeline of close to <a href=\"https:\/\/www.rootsanalysis.com\/blog\/2019\/10\/21\/gene-therapy-market-a-strong-pipeline-with-12-billion-opportunity-by-2030\/\">500 candidates <\/a>and support from almost all the <a href=\"https:\/\/www.rootsanalysis.com\/blog\/gene-therapy-market-big-pharma-bets-big\/\">big pharma players<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While several positives make us all very optimistic about the future of gene therapies, there are a few challenges that must be addressed before these therapies can achieve their true potential. Challenges related to pipeline development, platform selection, manufacturing, and reimbursement are amongst the top hurdles that these companies are currently facing. Also, the challenges related to supply chain and logistics are beginning to arise as these therapies reach the market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These&nbsp;logistical challenges are more pronounced when products are to be distributed to international markets. Given the lack of experience specific to gene therapies in the industry, the networks may not be as developed, and delay times at ports of entry may be ruinous to products with limited shelf lives. A few other industries that have faced such logistic issues in the past are &#8211; the food delivery market, and the rental cabs or bookings market. Earlier, it had become so difficult to track the status of your pizza order. But now, with the rise of mobile applications, you can track the progress in real-time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Let us imagine a scenario wherein you are celebrating the new year&#8217;s eve with your family. You have decided to order pizzas for the family from this amazing restaurant. You call the restaurant and place the order. The restaurant confirms your order and then the wait begins. 10 minutes&#8230;.20 minutes&#8230;30 minutes pass and you have no idea where your order is. The new year celebration excitement suddenly turns to anxiety and you are worried and unsure about when can you exactly expect your pizza.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Now let us think about what happens to a patient that is eligible for a gene therapy treatment. Given the exhaustive inclusion criteria, only a limited number of patients qualify for these therapies, and once they qualify, the wait begins. And it is not just the patient who is waiting, their entire family, along with the doctors are anxiously waiting for that personalized dose of cells to be delivered at the hospital bed that can finally cure the disease. If we are ready to stretch our imaginations, this wait and anxiety that the patient faces can easily be compared to the pizza hut craving that you were having on the new year&#8217;s eve.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The solution &#8211; simple. Get an App!!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Do what every company seems to be doing these days. Make personalized therapies even more personalized. Get an app that tells the patient the whereabouts of their therapy across the supply chain. Give the patient some control and <em>deliver not just a therapy, but an experience<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Some of the players, such as&nbsp;<em>(illustrative list)<\/em> Trakcel, Veeva, Be the Match BioTherapies, are already deploying solutions that can be used to efficiently manage and streamline various aspects of the complex supply chains of cell and advanced therapies. Presently, there are more than 160 innovative software-enabled systems for managing the cell and advanced therapies supply chain.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To know more about these developers, check the report here.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and Beperminogene Perplasmid (Japan), 2019 was a break out year for gene therapy developers. The $16 billion-plus investment by various investors finally seems to be paying off as we enter 2020 with a [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":16688,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47],"tags":[48,192],"class_list":["post-10721","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gene-therapy","tag-gene-therapy","tag-gene-therapy-supply-chain"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pizza Hut Prescription for Gene Therapy Companies<\/title>\n<meta name=\"description\" content=\"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pizza Hut Prescription for Gene Therapy Companies\" \/>\n<meta property=\"og:description\" content=\"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-01T06:15:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-30T16:08:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Gaurav Chaudhary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gaurav Chaudhary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/\"},\"author\":{\"name\":\"Gaurav Chaudhary\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\"},\"headline\":\"A Pizza Hut Prescription for Gene Therapy Companies\",\"datePublished\":\"2020-01-01T06:15:25+00:00\",\"dateModified\":\"2026-07-30T16:08:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/\"},\"wordCount\":570,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/RootsAnalysis_FeaturedImage_Pizza.webp\",\"keywords\":[\"Gene Therapy\",\"Gene Therapy Supply Chain\"],\"articleSection\":[\"Gene Therapy\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/\",\"name\":\"Pizza Hut Prescription for Gene Therapy Companies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/RootsAnalysis_FeaturedImage_Pizza.webp\",\"datePublished\":\"2020-01-01T06:15:25+00:00\",\"dateModified\":\"2026-07-30T16:08:43+00:00\",\"description\":\"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/RootsAnalysis_FeaturedImage_Pizza.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/RootsAnalysis_FeaturedImage_Pizza.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article Gene Therapy Companies at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/a-pizza-hut-prescription-for-gene-therapy-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Pizza Hut Prescription for Gene Therapy Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\",\"name\":\"Gaurav Chaudhary\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"caption\":\"Gaurav Chaudhary\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pizza Hut Prescription for Gene Therapy Companies","description":"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/","og_locale":"en_US","og_type":"article","og_title":"Pizza Hut Prescription for Gene Therapy Companies","og_description":"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...","og_url":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2020-01-01T06:15:25+00:00","article_modified_time":"2026-07-30T16:08:43+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp","type":"image\/webp"}],"author":"Gaurav Chaudhary","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Gaurav Chaudhary","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/"},"author":{"name":"Gaurav Chaudhary","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc"},"headline":"A Pizza Hut Prescription for Gene Therapy Companies","datePublished":"2020-01-01T06:15:25+00:00","dateModified":"2026-07-30T16:08:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/"},"wordCount":570,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp","keywords":["Gene Therapy","Gene Therapy Supply Chain"],"articleSection":["Gene Therapy"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/","url":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/","name":"Pizza Hut Prescription for Gene Therapy Companies","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp","datePublished":"2020-01-01T06:15:25+00:00","dateModified":"2026-07-30T16:08:43+00:00","description":"As we enter 2020, one drug class that is set to take-off is gene therapy. With three approvals (Zolgensma\u00ae (US), Zynteglo\u2122 (Europe) and...","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/01\/RootsAnalysis_FeaturedImage_Pizza.webp","width":150,"height":150,"caption":"This is a feature image for blog article Gene Therapy Companies at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/a-pizza-hut-prescription-for-gene-therapy-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"A Pizza Hut Prescription for Gene Therapy Companies"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc","name":"Gaurav Chaudhary","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","caption":"Gaurav Chaudhary"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=10721"}],"version-history":[{"count":7,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10721\/revisions"}],"predecessor-version":[{"id":22646,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10721\/revisions\/22646"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16688"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=10721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=10721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=10721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}